hydroxypropyl-gamma-cyclodextrin has been researched along with Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hildreth, JEK; Singhal, A; Song, B; Szente, L | 1 |
| Endo, F; Era, T; Furuya, H; Fusaki, N; Hamasaki, M; Ihn, H; Irie, T; Ishitsuka, Y; Matsuo, M; Nakagata, N; Nakamura, K; Soga, M; Yoneda, K | 1 |
2 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia
| Article | Year |
|---|---|
Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Cell Line; Cell Line, Tumor; Cholesterol; Endosomes; gamma-Cyclodextrins; HEK293 Cells; HeLa Cells; Humans; Lysosomal Membrane Proteins; Lysosomes; Niemann-Pick Disease, Type C; Protein Transport; Proteins; Proteomics | 2018 |
HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Coculture Techniques; Fibroblasts; gamma-Cyclodextrins; Humans; Induced Pluripotent Stem Cells; Mice; Niemann-Pick Disease, Type C; Treatment Outcome | 2015 |